NeoGenomics
NEO
14.82
-0.27
-1.79%
NeoGenomics
US · NEO
#2660 by market cap
Listed 1970
14.82
-0.27
-1.79%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
3
■ Upgrades■ Downgrades
- 3 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: BTIG moved from Hold to Buy on 2026-10-06.
Analyst consensus 9 analysts
Buy
Avg price target 24.71 +66.7%
Price target rangecurrent 14.82
Low20.00
Avg24.71
High35.00
Buy 78%
Hold 22%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-30 | Piper Sandler | -- | Buy | 24.00 |
| 2026-10-29 | TD Cowen | -- | Buy | 23.00 |
| 2026-10-29 | Piper Sandler | -- | Buy | 21.00 |
| 2026-10-29 | BofA Securities | -- | Hold | -- |
| 2026-10-29 | Jefferies | -- | Buy | 21.00 |
| 2026-10-29 | Needham | -- | Buy | 22.00 |
| 2026-10-29 | Leerink Partners | -- | Buy | 35.00 |
| 2026-10-07 | BofA Securities | -- | Hold | -- |
| 2026-10-06 | William Blair | -- | Hold | -- |
| 2026-10-06 | StoneX | -- | Buy | 20.00 |
| 2026-10-06 | Piper Sandler | -- | Buy | 21.00 |
| 2026-10-06 | BTIG | -- | Buy | 28.00 |
| 2026-10-06 | Needham | -- | Buy | 22.00 |
| 2026-08-27 | William Blair | -- | Hold | -- |
| 2026-08-27 | Piper Sandler | -- | Buy | 21.00 |
| 2026-08-24 | Piper Sandler | -- | Buy | 21.00 |
| 2026-07-29 | William Blair | -- | Hold | -- |
| 2026-07-29 | Craig-Hallum | -- | Buy | 19.00 |
| 2026-07-29 | Needham | -- | Buy | 19.00 |
| 2026-07-28 | TD Cowen | -- | Buy | 19.00 |
| 2026-07-28 | BTIG | -- | Hold | -- |
| 2026-07-24 | StoneX | -- | Buy | 16.00 |
| 2026-07-15 | TD Cowen | -- | Buy | 19.00 |
| 2026-07-13 | BofA Securities | -- | Hold | 16.00 |
| 2026-04-30 | Piper Sandler | -- | Buy | 13.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-06 | BTIG | Hold → Buy | 28.00 |
| 2026-04-29 | Leerink Partners | Hold → Buy | 25.00 |
| 2026-04-29 | Benchmark Co. | Hold → Buy | 11.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-28 | After close | ±13.06% | -0.33% (in line) |
| 2026/Q2 | 2026-07-28 | After close | ±15.40% | +13.96% (in line) |
| 2026/Q1 | 2026-04-28 | After close | ±15.52% | -0.67% (in line) |
| 2025/Q4 | 2026-02-17 | -- | ±11.42% | +0.53% (in line) |
| 2025/Q3 | 2025-10-28 | -- | ±19.66% | -2.36% (in line) |
| 2025/Q2 | 2025-07-29 | -- | ±22.35% | -18.73% (in line) |
| 2025/Q1 | 2025-04-29 | -- | ±21.67% | -34.00% (beat) |
| 2024/Q4 | 2025-02-18 | -- | ±12.23% | -13.97% (beat) |
| 2024/Q3 | 2024-11-05 | -- | ±12.24% | +5.59% (in line) |
| 2024/Q2 | 2024-07-29 | After close | ±18.04% | +17.96% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±15.41% | +0.29% (in line) |
| 2023/Q4 | 2024-02-20 | After close | ±18.23% | +12.11% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
NeoGenomics discussion 0 comments